Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤1500 g

Journal of Perinatology

Volumn 33, Issue 7, 2013, Pages 529-532

  Chong, E ^a   Reynolds, J ^a   Shaw, J ^b   Forur, L ^a   Delmore, P ^b   Uner, H ^c   Bloom, B T ^c   Gordon, P ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WESLEY MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

ampicillin; diaper rash; gentamicin; necrotizing enterocolitis; piperacillintazobactam

Indexed keywords

AMPICILLIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM;

APGAR SCORE; ARTICLE; COHORT ANALYSIS; CONGENITAL INFECTION; CONTROLLED STUDY; DEMOGRAPHY; DIAPER DERMATITIS; DRUG EXPOSURE; DRUG MONITORING; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PREMATURITY; RETROSPECTIVE STUDY; SIDE EFFECT;

ALKALINE PHOSPHATASE; AMPICILLIN; APGAR SCORE; DIAPER RASH; FEMALE; GENTAMICINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; PENICILLANIC ACID; PIPERACILLIN; RETROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 84879685091     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2012.169     Document Type: Article

References (20)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-247
2. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121: 689-696
3. Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010; 125: E1031-e1038
4. Marget W, Seeliger HP. Listeria monocytogenes infections-therapeutic possibilities and problems. Infection 1988; 16: S175-S177
5. Hof H. An update on the medical management of listeriosis. Expert Opin Pharmacother 2004; 5: 1727-1735
6. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sanchez PJ et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123: 58-66
7. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159: 392-397
8. Weintraub AS, Ferrara L, Deluca L, Moshier E, Green RS, Oakman E et al. Antenatal antibiotic exposure in preterm infants with necrotizing enterocolitis. J Perinatol 2012; 32: 705-709
9. Sheffield MJ, Lambert DK, Baer VL, Henry E, Butler A, Snow GL et al. Effect of ampicillin on bleeding time in very low birth-weight neonates during the first week after birth. J Perinatol 2011; 31: 477-480
10. Sheffield MJ, Lambert DK, Henry E, Christensen RD. Effect of ampicillin on the bleeding time of neonatal intensive care unit patients. J Perinatol 2009; 30: 527-530
11. Ealy M, Lynch KA, Meyer NC, Smith RJ. The prevalence of mitochondrial mutations associated with aminoglycoside-induced sensorineural hearing loss in an NICU population. Laryngoscope 2011; 121: 1184-1186
12. Boles RG, Friedlich P. Should patients be screened for 12S rRNA mutations before treatment with aminoglycosides? Mitochondrion 2010; 10: 391-392
13. Giapros VI, Cholevas VI, Andronikou SK. Acute effects of gentamicin on urinary electrolyte excretion in neonates. Pediatr Nephrol 2004; 19: 322-325
14. Chiruvolu A, Engle WD, Sendelbach D, Manning MD, Jackson GL. Serum calcium values in term and late-preterm neonates receiving gentamicin. Pediatr Nephrol 2008; 23: 569-574
15. Tugay S, Bircan Z, Caglayan C, Arisoy AE, Gokalp AS 2006Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol 21: 1389-1392
16. Reese J, Veldman A, Shah L, Vucovich M, Cotton RB. Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period. Semin Perinatol 2010; 34: 222-230
17. Mtitimila EI, Cooke RW 2004Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database Syst Rev CD004495
18. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117: 67-74
19. Kuck NA, Jacobus NV, Petersen PJ, Weiss WJ, Testa RT. Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Antimicrob Agents Chemother 1989; 33: 1964-1969
20. Daley D, Mulgrave L, Munro R, Neville S, Smith H, Dimech W. An evaluation of the in vitro activity of piperacillin/tazobactam. Pathology 1996; 28: 167-172